Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Lymphoma Article
This is a selection made from among articles on Drug Treatment Lymphoma. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Testing Tips
from: Drug testing is a way of assessing type and amount of legal or illegal drugs taken by a person. It is a self or laboratory process which looks for evidence of drug consumption by analyzing blood, hair, sweat, saliva or urinal samples.Tips for Parents :
Drugs among teenagers have been on the rise for some time now and have been a matter of concern to parents, family, local authorities and friends. The problem is much worse in the western countries, especially the US where teenage drug and alcohol abuse statistics show that the more and more children are falling victims to it. According to an annual survey of U.S. youth, three-fourths of 12th graders, more than two-thirds of 10th graders, and about two in every five 8th graders have consumed alcohol. How can one be sure if a teenager is on drugs? That one may be victims’ parent, a concerned school official or someone associated with a drug rehab center. Most of the children and young people are uncertain about the law concerning to drugs and the possible consequences for them in their future. If a child is caught in possession of a controlled drug they are bound to be committed a criminal offence and that will be documented by the police and also not permitted from taking up certain jobs or professions, and visiting other countries.
Tips for Employers :
Employers need consent from staff for drug testing in the workplace. Any employer will be keen to keep drug misuse away from the workplace. As well as causing ill health, drug misuse increases the chances of accidents at work and interferes with how much work is done. Because of the safety risks from drug misuse, workplace is recommended to have a policy on this matter. The policy could be drawn up between employee and employer or employee health and safety representatives. Employer has legal responsibilities to look after employee’s health and safety as far as reasonably possible and must assess any possible risks. However, there are some limits on what an employer can do to check on an employee's activities.
Teen drug and alcohol drug abuse could possibly happen in any home or school. If you think that the police will only arrest someone who's caught dealing drugs that is not true. Even using drugs for personal use may land a person in trouble and could lead to a large fine or time in prison.
About Author
Rapiddrugdetection.com is an online store offering drug tests and drug screening products in several formats including blood, urine and oral drug test kit. Rapiddrugdetection.com offers FDA-approved urine drug test as well as DOT-approved alcohol testing products. Some of the popular products are Marijuana Drug Testing, Breathalyzer and Saliva Drug Test.
Source: ArticleTrader.com
Drug Treatment Lymphoma Specific links
Drug Treatment Lymphoma News
RPT-Pfizer drug effective in rare children's cancers - Reuters
 KYW Newsradio | RPT-Pfizer drug effective in rare children's cancers Reuters * Crizotinib eradicated cancer in 7 of 8 lymphoma patients * Showed effect against 2 other rare, aggressive cancers * Was well-tolerated at high doses with minimal toxicity By Bill Berkrot May 16 (Reuters) - A Pfizer Inc lung cancer drug appears to be ... Pfizer Lung Drug Stops Deadly Child Cancers in Study Personalized Rx for Children Pfizer's targeted drug knocks out child cancers in small study |
Pfizer drug effective in rare children's cancers - Reuters
 Moneycontrol.com | Pfizer drug effective in rare children's cancers Reuters By Bill Berkrot (Reuters) - A Pfizer Inc lung cancer drug appears to be a highly effective treatment for children with a rare but aggressive type of lymphoma and other cancers, according to data from an early stage study released on Wednesday. Lung Cancer Drug Treats Rare Lymphoma Tumors, Too Children with Cancer Have Complete Responses in a Children's Oncology Group ... Experimental Drug Helps Fight Some Childhood Cancers, Study Finds |
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 - Xconomy
Seattle Genetics Follows the Science, Taking on Rare Lymphoma No. 3 Xconomy That could open the door to treating another 1000 new patients a year in the US, expanding the number of people eligible to get the drug by about 35 percent. Cutaneous T-cell lymphoma comes in a lot of different forms, and although it doesn't usually ... Seattle Genetics Announces Health Canada Accepts ADCETRIS® New Drug Submission ... |
Treatment helps woman make most of life after cancer - UAB News
 UAB News | Treatment helps woman make most of life after cancer UAB News The drug has proven to be effective in trials for Hodgkin's lymphoma and anaplastic large cell lymphomas that were resistant to prior therapies or came back after a period of time. The FDA approved SGN-35, now known as Adcetris, for treatment of these ... |
Brentuximab Vedotin Effective in Large-Cell Lymphoma - Doctors Lounge
Brentuximab Vedotin Effective in Large-Cell Lymphoma Doctors Lounge More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete remission, according to the results of a phase II study ... |
Seattle Genetics Announces Health Canada Accepts ADCETRIS(R) New Drug ... - MarketWatch (press release)
Seattle Genetics Announces Health Canada Accepts ADCETRIS(R) New Drug ... MarketWatch (press release) ADCETRIS is an antibody-drug conjugate (ADC) directed to CD30, which is expressed in Hodgkin lymphoma and sALCL. "Data from the pivotal clinical trials of ADCETRIS in relapsed HL and sALCL demonstrated a high objective response rate and manageable ... |
Cell Therapeutics' Lymphoma Drug Wins Conditional EU Approval - Wall Street Journal
Cell Therapeutics' Lymphoma Drug Wins Conditional EU Approval Wall Street Journal Cell Therapeutics Inc. (CTIC) won conditional authorization to market its treatment for non-Hodgkin B-cell lymphomas in the European Union, a key regulatory win for the drug maker. Shares were halted at $1.04 Thursday ahead of the news. Drug Approval! Oh, Wait, We Knew That Already. Can A European Approval of Pixantrone Save Cell Therapeutics? (CTIC) |
American Society of Hematology Statement on Senate Passage of Prescription ... - MarketWatch (press release)
American Society of Hematology Statement on Senate Passage of Prescription ... MarketWatch (press release) ASH is the world's largest professional society concerned with the causes and treatment of blood disorders, representing more than 14000 members who specialize in blood cancers such as leukemia, lymphoma, and myeloma, as well as serious blood diseases ... |
City of Hope Receives $5 Million Grant to Develop T Cell Treatment Targeting ... - MarketWatch (press release)
City of Hope Receives $5 Million Grant to Develop T Cell Treatment Targeting ... MarketWatch (press release) City of Hope is a pioneer in T cell immunotherapy research, helping to develop genetically modified T cells as a treatment for cancer. This strategy, termed "adoptive T cell therapy," focuses on redirecting a patient's immune system to specifically ... |
Trial Supports Earlier Use of a Prostate Cancer Drug - New York Times
 New York Times | Trial Supports Earlier Use of a Prostate Cancer Drug New York Times A new drug used to treat advanced prostate cancer may also help men if used early in the course of the disease, before an operation, researchers reported Wednesday. In a small clinical trial, six months of treatment with the drug, Johnson & Johnson's ... ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of ... |